Visikol, Inc.

Visikol is a contract research services company that is focused on accelerating the drug discovery and development process through providing its clients with advanced tissue imaging and advanced cell culture services. Today, Visikol counts the top twenty pharmaceutical companies as clients and has been instrumental in dozens of drug discovery programs.

The company provides end-to-end services that include3D tissue imaging,multiplex tissue imaging,digital pathology,high content imaging,2D cell culture assays, 3D cell culture assays and ex vivo tissue slice assays. Visikol’s expertise lies in both transforming tissues into actionable insights as well as bridging the gap between in vitro assays and in vivo results through the use of best-in-classcell culture models.

In addition to its services, Visikol sells a suite oftissue clearing reagents and kitsas well as theHUREL® Micro Liver portfolioof primary hepatocyte liver models.